8 Biggest Mid-Day Losers For Friday

Juno Therapeutics Inc JUNO shares dipped 31.3 percent to $28.04 after the company announced JCAR015's Phase 2 trial was put on hold after two patients died last week.
T2 Biosystems Inc TTOO shares declined 20 percent to $6.09. T2 Biosystems extended timeline for the completion of the T2Bacteria trial. BTIG downgraded the rating on T2 Biosystems from Buy to Sell, while lowering the price target from $12 to $4.
PriceSmart, Inc. PSMT shares fell 10.4 percent to $81.99 as the company posted weaker-than-expected results for the third quarter. The company’s same store sales declined 1.9 percent for June.
Galena Biopharma Inc GALE dropped 11.5 percent to $0.456. Galena Biopharma priced 28 million shares at $0.45 per share.
Versar Inc. VSR shares declined 9.1 percent to $1.45.
Exeter Resource Corp XRA fell 8.5 percent to $1.24.
Kite Pharma Inc KITE shares fell 8 percent to $47.93 after Juno Therapeutics reported an FDA clinical hold on JCAR015's Phase 2 trial.
Dataram Corp DRAM shares declined 7.4 percent to $0.500. Dataram reported a 1-for-3 reverse stock split.